Xin Qi Selected Research

undecylprodigiosin

1/2020	Correction: Undecylprodigiosin Induced Apoptosis in P388 Cancer Cells Is Associated with Its Binding to Ribosome.
1/2013	Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Qi Research Topics

Disease

54	Neoplasms (Cancer) 07/2022 - 09/2008
25	Infections 05/2022 - 02/2012
14	Breast Neoplasms (Breast Cancer) 04/2022 - 03/2011
13	Inflammation (Inflammations) 07/2022 - 10/2004
12	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 04/2014
11	Fibrosis (Cirrhosis) 01/2023 - 07/2011
11	COVID-19 05/2022 - 01/2021
8	Neoplasm Metastasis (Metastasis) 03/2022 - 09/2008
8	Lung Neoplasms (Lung Cancer) 01/2021 - 03/2015
8	Heart Failure 01/2020 - 04/2009
8	Ischemia 01/2020 - 10/2004
6	Hypoxia (Hypoxemia) 03/2022 - 10/2004
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2014
6	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 02/2013
6	Wounds and Injuries (Trauma) 10/2020 - 01/2016
6	Osteoarthritis 06/2020 - 01/2019
5	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 06/2014
5	Knee Osteoarthritis 03/2022 - 01/2018
5	Huntington Disease (Huntington's Disease) 01/2021 - 12/2013
5	Hypertension (High Blood Pressure) 12/2020 - 01/2011
4	Hemorrhage 01/2023 - 01/2017
4	Graves Ophthalmopathy 04/2022 - 01/2021
4	Brain Injuries (Brain Injury) 03/2022 - 08/2019
4	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2020
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 08/2016
4	Pain (Aches) 06/2020 - 01/2019
4	Osteonecrosis (Kienbock's Disease) 01/2020 - 01/2016
4	Myocardial Infarction 11/2019 - 08/2006
4	Parkinson Disease (Parkinson's Disease) 01/2019 - 02/2013
4	Infarction (Infarctions) 01/2015 - 10/2004
3	Cerebral Hemorrhage 01/2023 - 01/2019
3	Body Weight (Weight, Body) 07/2022 - 11/2011
3	Carcinogenesis 03/2022 - 01/2020
3	Stroke (Strokes) 01/2022 - 10/2004
3	Brain Ischemia (Cerebral Ischemia) 01/2022 - 10/2004
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 03/2010
3	Mental Disorders (Mental Disorder) 01/2021 - 01/2020
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2020 - 12/2019
3	Reperfusion Injury 04/2020 - 07/2014
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2018
3	Gliosis 01/2020 - 01/2016
3	Insulin Resistance 01/2020 - 07/2013
3	Chronic Pain 02/2019 - 01/2019
3	Trichinellosis 12/2018 - 09/2015
3	Necrosis 03/2018 - 08/2015

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2004
18	Biomarkers (Surrogate Marker)IBA 05/2022 - 09/2008
15	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
14	Messenger RNA (mRNA)IBA 03/2022 - 11/2004
10	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2017
10	Biological ProductsIBA 03/2022 - 12/2011
9	Peptides (Polypeptides)IBA 01/2020 - 01/2008
8	CateninsIBA 01/2022 - 10/2011
8	EnzymesIBA 08/2021 - 01/2017
6	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 07/2013
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 02/2013
5	IronIBA 04/2022 - 06/2016
5	AdipokinesIBA 03/2022 - 01/2018
5	Long Noncoding RNAIBA 03/2022 - 01/2019
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 08/2016
5	HydrogelsIBA 01/2020 - 01/2018
5	VaccinesIBA 12/2018 - 11/2016
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 10/2004
4	CytokinesIBA 01/2023 - 01/2012
4	Competitive Endogenous RNAIBA 03/2022 - 01/2020
4	Therapeutic UsesIBA 01/2022 - 10/2011
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2021 - 03/2015
4	CollagenIBA 01/2021 - 01/2018
4	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2011
4	AlkaloidsIBA 01/2017 - 12/2011
4	AntigensIBA 11/2016 - 09/2014
3	Circular RNAIBA 10/2022 - 01/2019
3	LigandsIBA 01/2022 - 07/2014
3	Troleandomycin (TAO)FDA Link 01/2022 - 01/2021
3	LipidsIBA 01/2022 - 01/2020
3	Acid Sensing Ion ChannelsIBA 01/2022 - 01/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2014
3	Hematoxylin (Haematoxylon)IBA 01/2021 - 04/2014
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 04/2014
3	Oxygen (Dioxygen)IBA 01/2021 - 10/2018
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 11/2016
3	Antineoplastic Agents (Antineoplastics)IBA 11/2020 - 05/2016
3	Blood Proteins (Serum Proteins)IBA 06/2020 - 01/2020
3	Retinaldehyde (Retinal)IBA 01/2020 - 10/2014
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 02/2018
3	CarbohydratesIBA 01/2020 - 08/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2014
3	Phosphotransferases (Kinase)IBA 01/2020 - 01/2015
3	Angiotensin IIIBA 01/2020 - 01/2017
3	pro-brain natriuretic peptide (1-76)IBA 07/2018 - 06/2017
3	Complement System Proteins (Complement)IBA 06/2017 - 12/2016

Therapy/Procedure

27	Therapeutics 01/2023 - 11/2014
9	Radiotherapy 03/2022 - 12/2014
6	Hip Replacement Arthroplasty (Total Hip Replacement) 10/2020 - 11/2012
5	Drug Therapy (Chemotherapy) 01/2021 - 09/2008
4	Precision Medicine 01/2022 - 01/2015
4	Prostheses and Implants (Prosthesis) 06/2020 - 11/2012
3	Aftercare (After-Treatment) 01/2021 - 11/2015
3	Arthroplasty 01/2020 - 08/2015
3	Intraperitoneal Injections 02/2019 - 01/2017